Chemed Corporation
US ˙ NYSE ˙ US16359R1032

SecurityCHE / Chemed Corporation
InstitutionAperio Group, LLC
Latest Disclosed Ownership22,051 shares
Latest Disclosed Value $ 11,745,000
Aperio Group, LLC reports 18.47% increase in ownership of CHE / Chemed Corporation

On February 5, 2021 - Aperio Group, LLC filed a 13F-HR form disclosing ownership of 22,051 shares of Chemed Corporation (US:CHE) valued at $11,744,583 USD as of December 31, 2020. The entity filed a previous 13F-HR on November 6, 2020 disclosing 18,613 shares of Chemed Corporation. This represents a change in shares of 18.47% during the quarter. The current value of the position is $9,737,501 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2021-02-05 2020-12-31 13F CHEMED CORP COM 16359R103 22,051 3,438 18.47 11,745 31.38 0.0348
2020-11-06 2020-09-30 13F CHEMED CORP COM 16359R103 18,613 1,398 8.12 8,940 15.12 0.0302
2020-08-13 2020-06-30 13F CHEMED CORP COM 16359R103 17,215 -2,122 -10.97 7,766 -7.28 0.0287
2020-05-05 2020-03-31 13F CHEMED CORP COM 16359R103 19,337 -1,768 -8.38 8,376 -9.64 0.0370
2020-02-13 2019-12-31 13F CHEMED CORP COM 16359R103 21,105 -2,860 -11.93 9,270 -7.37 0.0333
2019-11-06 2019-09-30 13F CHEMED CORP COM 16359R103 23,965 6,072 33.94 10,008 55.02 0.0396
2019-07-30 2019-06-30 13F CHEMED CORP COM 16359R103 17,893 3,303 22.64 6,456 38.24 0.0264
2019-05-13 2019-03-31 13F CHEMED CORP COM 16359R103 14,590 156 1.08 4,670 14.21 0.0202
2019-05-06 2018-12-31 13F/A-1 CHEMED CORP COM 16359R103 14,434 -2,858 -16.53 4,089 -26.00 0.0206
2019-02-14 2018-12-31 13F CHEMED CORP COM 16359R103 14,552 -2,740 4,122
2019-05-06 2018-09-30 13F/A-1 CHEMED CORP COM 16359R103 17,292 1,943 12.66 5,526 11.88 0.0244
2018-10-17 2018-09-30 13F CHEMED COMMON 16359R103 17,292 1,943 5,526
2019-05-06 2018-06-30 13F/A-1 CHEMED CORP COM 16359R103 15,349 -128 -0.83 4,939 16.95 0.0236
2018-07-30 2018-06-30 13F CHEMED COMMON 16359R103 15,349 -128 4,939
2019-05-01 2018-03-31 13F/A-1 CHEMED CORP COM 16359R103 15,477 221 1.45 4,223 13.89 0.0210
2018-05-08 2018-03-31 13F CHEMED COMMON 16359R103 15,477 221 4,223
2019-05-01 2017-12-31 13F/A-1 CHEMED CORP COM 16359R103 15,256 205 1.36 3,708 21.93 0.0191
2018-02-02 2017-12-31 13F CHEMED COMMON 16359R103 15,256 205 3,708
2019-05-01 2017-09-30 13F/A-1 CHEMED CORP COM 16359R103 15,051 -494 -3.18 3,041 -4.34 0.0172
2017-10-25 2017-09-30 13F CHEMED COMMON 16359R103 15,051 -494 3,041
2019-04-22 2017-06-30 13F/A-1 CHEMED CORP COM 16359R103 15,545 1,011 6.96 3,179 19.74 0.0195
2017-07-18 2017-06-30 13F CHEMED COMMON 16359R103 15,545 1,011 3,179
2019-04-22 2017-03-31 13F/A-1 CHEMED CORP COM 16359R103 14,534 668 4.82 2,655 19.33 0.0182
2017-05-05 2017-03-31 13F CHEMED COMMON 16359R103 14,534 668 2,655
2019-04-22 2016-12-31 13F/A-1 CHEMED CORP COM 16359R103 13,866 -32,336 -69.99 2,225 -65.86 0.0170
2017-02-14 2016-12-31 13F CHEMED COMMON 16359R103 13,866 -32,336 2,224
2019-04-12 2016-09-30 13F/A-1 CHEMED CORP COM 16359R103 46,202 -259 -0.56 6,518 2.92 0.0472
2016-11-01 2016-09-30 13F CHEMED COMMON 16359R103 46,202 -259 6,518
2019-04-12 2016-06-30 13F/A-1 CHEMED CORP COM 16359R103 46,461 -1,104 -2.32 6,333 -1.71 0.0495
2016-08-12 2016-06-30 13F CHEMED COMMON 16359R103 46,461 -1,104 6,333
2019-04-12 2016-03-31 13F/A-1 CHEMED CORP COM 16359R103 47,565 -747 -1.55 6,443 -10.97 0.0551
2016-04-28 2016-03-31 13F CHEMED COMMON 16359R103 47,565 -747 6,443
2016-01-21 2015-12-31 13F CHEMED COMMON 16359R103 48,312 -27,426 -36.21 7,237 -28.41 0.0663
2015-10-19 2015-09-30 13F CHEMED COMMON 16359R103 75,738 113 0.15 10,109 1.97 0.1029
2015-07-29 2015-06-30 13F CHEMED COMMON 16359R103 75,625 1,153 1.55 9,914 11.49 0.1023
2015-04-29 2015-03-31 13F CHEMED COMMON 16359R103 74,472 74,472 0.00 8,892 0.0996
2015-01-30 2014-12-31 13F CHEMED COMMON 16359R103 0 -3,699 -100.00 0 -100.00
2014-10-21 2014-09-30 13F CHEMED COMMON 16359R103 3,699 369 11.08 381 22.12 0.0051
2014-07-23 2014-06-30 13F CHEMED COMMON 16359R103 3,330 1,062 46.83 312 53.69 0.0045
2014-04-25 2014-03-31 13F CHEMED COMMON 16359R103 2,268 203
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.